When Ethics Take a Backseat at 30,000 Feet
(Lanka-e-News -07.March.2025, 11.30 PM) Emirates Airline, a name synonymous with luxury, efficiency, and world-class service, finds itself embroiled in an unsettling controversy that strikes at the heart of corporate ethics and passenger rights. At the center of this scandal is none other than PTM Deniya, the Colombo Airport Station Manager, accused of coercing passengers—many merely transiting via Dubai—into obtaining unnecessary and overpriced PCR tests from Ashiri Laboratory during the peak of the COVID-19 pandemic.
This wasn’t just a matter of enforcing airline policy; it was a shakedown—one that forced passengers to pay for tests they didn’t need, from a facility conveniently located in the airport parking lot. If that weren’t damning enough, eyewitnesses and recorded evidence suggest that Deniya not only walked passengers through the corrupt process but also personally collected payments and facilitated payouts to Ashiri Laboratories.
While Emirates prides itself on a reputation of trust and global excellence, the inertia displayed in addressing these serious allegations raises a troubling question: Has Emirates become complicit in third-world corruption, or is this an isolated rot left unchecked?
Picture this: A dual UK-US citizen walks into Ashiri Laboratory, as directed by Emirates staff. The reason? They were told—no, forced—to take a PCR test, despite merely transiting through Dubai, a category of traveler for whom no such requirement existed.
The passenger in question soon found out that the test itself was a mirage.
"Oh, you don’t have to do anything. Just pay 7500 rupees, and they’ll give you the test result."
Wait, what? No swab, no sample, no medical procedure—just money changing hands, and a test certificate appearing like magic.
The astonished passenger inquired: How can they issue a test result without an actual test?
The response from Emirates ground staff was a masterclass in brazen indifference:
"That’s how it works. Emirates doesn’t care. We only need a test result. If you don’t pay, you don’t fly."
Enter PTM Deniya, the enforcer of this operation, casually strolling through the Ashiri Laboratory, overseeing stacks of test certificates being issued without medical evaluation. He allegedly collected bundles of cash, counted the payments, and ensured that his "partners" at Ashiri Laboratories received their cut.
This wasn’t about passenger safety. It was pure racketeering.
The evidence against PTM Deniya and the Ashiri Laboratory scam didn’t remain in the shadows. Passengers complained. They provided recordings, eyewitness accounts, and official complaints to Emirates' Dubai headquarters.
And what happened?
Absolutely nothing.
Complaints fell on deaf ears, ignored by an airline that touts itself as a model of corporate governance. Even as the scandal gained traction—reaching Washington and London, prompting formal cases being filed in the US—Emirates seemed determined to bury the matter.
But why? Was it negligence? An unwillingness to admit wrongdoing? Or something far worse—a tacit acknowledgment that this was "business as usual" in certain parts of the world?
Years after the events transpired, the U.S. has now taken an interest in the case, prompting Emirates to revisit the complaints it previously dismissed. With Washington pushing for accountability, the airline faces a stark choice:
Acknowledge the wrongdoing, apologize, and offer refunds to affected passengers who were forced to pay for fraudulent PCR tests.
Continue to ignore the scandal and risk a full-scale U.S. investigation, which could lead to sanctions, lawsuits, and irreparable damage to its brand.
If Emirates fails to take action, the implications could be severe:
Legal Consequences: U.S. and UK passengers who were victims of the scheme could file lawsuits against the airline, dragging it into court battles in multiple jurisdictions.
Reputational Damage: In an era where public trust is everything, no amount of luxury lounges or fine champagne can mask corporate malpractice. The airline risks being labeled as a carrier that enables corruption.
Regulatory Scrutiny: If U.S. authorities determine that Emirates was complicit—or even negligent—in failing to address the corruption, the airline could face stricter regulations or fines when operating in Western markets.
Let’s be clear: PTM Deniya is no rogue employee.
He’s a station manager—a person entrusted with upholding Emirates’ operational integrity at a major international airport. That means he either:
Acted alone in running this scheme, which would be a failure of oversight on Emirates' part, or
Had implicit approval from higher-ups, which would suggest a deep-rooted culture of corruption within the airline’s Colombo operations.
Either way, the Dubai Royal Family, which holds Emirates as one of its prized assets, will not take kindly to such unethical conduct dragging the airline’s name through the mud.
Emirates has reached a crossroads. If it values its global reputation, credibility, and long-term success, it must take decisive action:
Immediate Investigation: Conduct an independent audit into PTM Deniya’s tenure, examining all financial transactions related to PCR testing at Bandaranaike International Airport.
Accountability Measures: If evidence confirms corruption, terminate PTM Deniya and any other implicated staff members, while publicly acknowledging the misconduct.
Refund and Apologize: Emirates must refund passengers who were forced to pay for fraudulent PCR tests and issue a formal apology for failing to act sooner.
Policy Reforms: Implement stricter anti-corruption measures within its airport operations worldwide to prevent similar incidents in the future.
The world admired Emirates for its rise to aviation excellence, but excellence means nothing without integrity.
The PTM Deniya scandal is a stain on Emirates’ reputation, but it is not an irreversible one—provided the airline takes swift and decisive action.
The real question is: Will Emirates step up, clean house, and reaffirm its commitment to passenger trust?
Or will it continue to turn a blind eye, only to find itself battling legal repercussions and public outrage in the years to come?
One thing is certain—the world is watching.
-By A Special Correspondent
---------------------------
by (2025-03-07 21:01:56)
Read 29640 Times
Leave a Reply
0 discussion on this news